Tech Company Financing Transactions

Cytrellis Biosystems Funding Round

Cytrellis Biosystems secured a $50 million Series C investment round on 9/22/2021. Investors included D1 Capital Partners, Arch Venture Partners and Partner Fund Management.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

299C Washington St.
Woburn, MA 01801
USA

Phone

(857) 254-1720

Website

www.cytrellis.com

Email Address

[email protected]

Overview

Cytrellis Biosystems, Inc. is a clinical stage medical technology company developing a new, proprietary class of aesthetic devices.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Karen Cronholm

        

Chief Financial Officer

Diane Marcou

        

VP - Marketing

Cathleen Alaimo

        

VP - R & D

Steve Gemmell

        

VP - Sales

Michael Williams

        

Browse more venture capital transactions:

Prev: 9/22/2021: Provi venture capital transaction
Next: 9/22/2021: Metrika Intelligence venture capital transaction

Share this article

News on VC Transactions

Our team works diligently to report on all VC transactions involving tech companies. All VC database entries reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary